Forbes B A, Hicks K E
Department of Clinical Pathology, S.U.N.Y. Health Science Center, Syracuse 13210.
J Clin Microbiol. 1994 Jul;32(7):1725-8. doi: 10.1128/jcm.32.7.1725-1728.1994.
Introduction of PCR to directly detect Mycobacterium tuberculosis in clinical specimens has shown promise; however, interfering substances in clinical material have contributed to lowered assay sensitivities. We evaluated the ability of a PCR assay to detect M. tuberculosis in BACTEC 12B broth cultures. Clinical specimens were processed and inoculated into BACTEC 12B vials. Evaluation was approached in two phases, starting with an initial evaluation in which an aliquot of 12B broth was removed when the growth index (GI) was > or = 10 and stored at 4 degrees C until assayed by PCR. Of the 290 specimens initially assayed, 129 were culture negative for mycobacteria as well as PCR negative for M. tuberculosis. Except for one, cultures (n = 102) which grew mycobacteria other than M. tuberculosis were all PCR negative. The remaining 59 broths were all culture and PCR positive for M. tuberculosis; 39% (n = 23) of these cultures when assayed by PCR had GIs of < or = 50. Following initial evaluation, 200 12B BACTEC vials with GIs of > or = 10 were assayed in a similar manner except that specimens were amplified twice weekly to determine PCR's impact on the length of time to identification of M. tuberculosis as compared with standard laboratory practices. Utilization of PCR resulted in a mean time to detection of M. tuberculosis of 14 days, compared with 29 days by using commercially available nucleic acid probes to identify M. tuberculosis complex from growth of BACTEC 12B subcultures on solid media. In light of an overall sensitivity and specificity of 100 and 99.7%, respectively, coupled with the ability to identify M. tuberculosis days or weeks before other methods can be applied, we conclude that PCR might prove to be a rapid alternative for identification of M. tuberculosis in culture and allow for earlier setup of susceptibility testing.
将聚合酶链反应(PCR)用于直接检测临床标本中的结核分枝杆菌已显示出前景;然而,临床材料中的干扰物质导致检测灵敏度降低。我们评估了一种PCR检测方法在BACTEC 12B肉汤培养物中检测结核分枝杆菌的能力。临床标本经过处理后接种到BACTEC 12B小瓶中。评估分两个阶段进行,首先是初始评估,当生长指数(GI)≥10时,取出一份12B肉汤,保存在4℃直至通过PCR检测。在最初检测的290份标本中,129份结核分枝杆菌培养阴性且结核分枝杆菌PCR检测阴性。除一份外,培养出非结核分枝杆菌的培养物(n = 102)PCR检测均为阴性。其余59份肉汤结核分枝杆菌培养和PCR检测均为阳性;这些培养物经PCR检测时,39%(n = 23)的GI≤50。初始评估后,对200份GI≥10的12B BACTEC小瓶以类似方式进行检测,不同之处在于标本每周扩增两次,以确定与标准实验室操作相比,PCR对结核分枝杆菌鉴定所需时间的影响。与使用市售核酸探针从BACTEC 12B固体培养基亚培养物生长中鉴定结核分枝杆菌复合群相比,使用PCR检测结核分枝杆菌的平均时间为14天,而使用核酸探针的时间为29天。鉴于总体灵敏度和特异性分别为100%和99.7%,再加上能够比其他方法提前数天或数周鉴定结核分枝杆菌,我们得出结论,PCR可能被证明是培养物中鉴定结核分枝杆菌的快速替代方法,并允许更早地进行药敏试验。